Valneva SE’s Covid-19 vaccine won approval from the U.K. drugs regulator, the shot’s first regulatory clearance. The stock soared.
The decision caps “a rigorous review” of the vaccine’s safety and effectiveness, June Raine, chief executive of the Medicines and Healthcare Products Regulatory Agency, said in a statement Thursday.
